Riskpilot← Back to searchSign inGet full accessNectar Willeshave P/S
KASActiveCVR 41735821Bornholmsgade 3Development of building projects · NACE 6812Est. 2020— employees
Revenue 2025
DKK 3,6M
0% vs 2024
EBITDA margin
163.1%
+36% vs 2024
Equity ratio
33.6%
Financial strength
Net profit 2025
DKK 3,1M
+194% vs 2024
| Revenue | DKK 3,6M | +0% |
| EBITDA | DKK 5,9M | +36% |
| Net profit | DKK 3,1M | +194% |
| Total assets | DKK 93,4M | +3% |
| Equity | DKK 31,4M | +11% |
| Employees | — | — |
Legal name
Nectar Willeshave P/S
CVR number
41735821
Legal form
Kommanditaktieselskab/Partnerselskab
NACE code
6812 · Development of building projects
Founded
30. september 2020
Share capital
DKK 680.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af komplementaren, af 2 bestyrelsesmedlemmer i forening, eller af den samlede bestyrelse.
Company purpose
Selskabet formål er at drive virksomhed med ejendomsudvikling samt hermed beslægtet virksomhed.
Address
Bornholmsgade 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 267 | 3.669 | 3.627 | 3.643 |
| Staff expenses | -0 | -0 | -0 | -0 |
| EBITDA | 9.285 | 3.323 | 4.377 | 5.943 |
| Depreciation & amort. | -0 | -0 | -0 | -0 |
| EBIT | 9.285 | 3.323 | 4.377 | 5.943 |
| Net financials | -408 | -3.217 | -3.311 | -2.813 |
| Profit before tax | 8.878 | 105 | 1.065 | 3.130 |
| Tax | -0 | -0 | -0 | -0 |
| Net profit | 8.878 | 105 | 1.065 | 3.130 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 96.979 | 90.307 | 90.968 | 93.371 |
| Equity | 27.090 | 27.196 | 28.261 | 31.391 |
| Long-term debt | 60.605 | 60.700 | 60.218 | 59.462 |
| Short-term debt | 9.285 | 2.411 | 2.489 | 2.517 |
| Total debt | 69.889 | 63.111 | 62.707 | 61.979 |
EBITDA margin
163.1%
This company
15.8%
Market median
+932% vs market
20222025
Equity ratio
33.6%
This company
38.2%
Market median
+12% vs market
20222025
Return on equity
10.0%
This company
18.4%
Market median
-46% vs market
20222025
Net profit margin
85.9%
This company
8.1%
Market median
+960% vs market
20222025
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
20222025
Debt / equity
1.97×
This company
0.62×
Market median
-218% vs market
20222025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-02-01 – 2022-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BK Management | Management | 2022 | — | — |
VS Management | Management | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
PharmaService I/S | Company | 90.0% | 90.0% | 2023 |
Nectar Invest A/S | Company | 10.0% | 10.0% | 2023 |
Nectar KK Holding P/S | Company | 100.0% | 100.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PharmaService I/S
Nectar Willeshave P/S Board members of Nectar Willeshave P/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bjørk Krogshave | Management | 0 companies |
| Vivi Sørensen | Management | 0 companies |
| Peer Thomas Borg | Chairman | 0 companies |
| Rune Bech Kjældgaard | Board of Directors | 0 companies |
| Robert Andersen | Chairman | 0 companies |
| Niels Christian Thorbjørn Olsen | Board of Directors | 0 companies |
| Tommas Jakobsen | Board of Directors | 0 companies |
| Peter Graversen | Board of Directors | 0 companies |